tagraxofusp
tagraxofusp is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Elzonris. Available dosage form: injection, solution.
Drug Details
- Generic Name
- tagraxofusp
- Brand Names
- Elzonris
- Application Number
- BLA761116
- Sponsor
- Stemline Therapeutics, Inc.
- NDC Codes
- 1
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- TAGRAXOFUSP
Indications and Usage
1 INDICATIONS AND USAGE ELZONRIS is indicated for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years and older. ELZONRIS is a CD123-directed cytotoxin indicated for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years and older ( 1 )